Watchlist Price Alert

Carmell Therapeutics Corp... (CTCX)

NASDAQ: CTCX · Real-Time Price · USD

0.20

0.01 (2.77%)

At close: Mar 07, 2025, 3:55 PM

Carmell Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-15.45M	-9.05M	-6.48M
Depreciation & Amortization	124.79K	242.56K	242.12K
Stock-Based Compensation	667.68K	636.37K	246.8K
Other Working Capital	-2.97M	1.28M	872.37K
Other Non-Cash Items	9.73M	2.6M	1.35M
Deferred Income Tax	n/a	-194.59K	2.52M
Change in Working Capital	-3.42M	2.34M	952.69K
Operating Cash Flow	-8.35M	-3.43M	-1.18M
Capital Expenditures	-30.47K	-7.16K	-7.27K
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-154.44M
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	154.44M
Investing Cash Flow	-30.47K	-7.16K	-7.27K
Debt Repayment	-3.2M	2.75M	1.12M
Common Stock Repurchased	n/a	-2.29K	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	14.32M	-256.34K	67.82K
Financial Cash Flow	11.16M	3.55M	1.2M
Net Cash Flow	2.78M	115.79K	11.21K
Free Cash Flow	-8.38M	-3.44M	-1.18M